Golden State Wealth Management, LLC Astrazeneca PLC Transaction History
Golden State Wealth Management, LLC
- $673 Billion
- Q1 2025
A detailed history of Golden State Wealth Management, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Golden State Wealth Management, LLC holds 822 shares of AZN stock, worth $57,186. This represents 0.01% of its overall portfolio holdings.
Number of Shares
822
Previous 4,176
80.32%
Holding current value
$57,186
Previous $306,000
19644.44%
% of portfolio
0.01%
Previous 0.02%
Shares
7 transactions
Others Institutions Holding AZN
# of Institutions
1,381Shares Held
475MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.2 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$2.85 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.61 Billion0.48% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.67 Billion0.13% of portfolio
-
Franklin Resources Inc San Mateo, CA19.5MShares$1.36 Billion0.37% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $216B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...